Biosynthesis of Drug Glucuronide Metabolites in the Budding Yeast Saccharomyces cerevisiae

Glucuronidation is one of the most common pathways in mammals for detoxification and elimination of hydrophobic xenobiotic compounds, including many drugs. Metabolites, however, can form active or toxic compounds, such as acyl glucuronides, and their safety assessment is often needed. The absence of...

Full description

Saved in:
Bibliographic Details
Published in:Molecular pharmaceutics 2016-07, Vol.13 (7), p.2274-2282
Main Authors: Ikushiro, Shinichi, Nishikawa, Miyu, Masuyama, Yuuka, Shouji, Tadashi, Fujii, Miharu, Hamada, Masahiro, Nakajima, Noriyuki, Finel, Moshe, Yasuda, Kaori, Kamakura, Masaki, Sakaki, Toshiyuki
Format: Article
Language:English
Subjects:
Animals
Carboxylic Acids - metabolism
Glucuronides - metabolism
Glucuronosyltransferase - metabolism
Humans
Oxidoreductases - metabolism
Saccharomyces cerevisiae - metabolism
Saccharomycetales - metabolism
Umbelliferones - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glucuronidation is one of the most common pathways in mammals for detoxification and elimination of hydrophobic xenobiotic compounds, including many drugs. Metabolites, however, can form active or toxic compounds, such as acyl glucuronides, and their safety assessment is often needed. The absence of efficient means for in vitro synthesis of correct glucuronide metabolites frequently limits such toxicological analyses. To overcome this hurdle we have developed a new approach, the essence of which is a coexpression system containing a human, or another mammalian UDP-glucuronosyltransferases (UGTs), as well as UDP-glucose-6-dehydrogenase (UGDH), within the budding yeast, Saccharomyces cerevisiae. The system was first tested using resting yeast cells coexpressing UGDH and human UGT1A6, 7-hydroxycoumarin as the substrate, in a reaction medium containing 8% glucose, serving as a source of UDP-glucuronic acid. Glucuronides were readily formed and recovered from the medium. Subsequently, by selecting suitable mammalian UGT enzyme for the coexpression system we could obtain the desired glucuronides of various compounds, including molecules with multiple conjugation sites and acyl glucuronides of several carboxylic acid containing drugs, namely, mefenamic acid, flufenamic acid, and zomepirac. In conclusion, a new and flexible yeast system with mammalian UGTs has been developed that exhibits a capacity for efficient production of various glucuronides, including acyl glucuronides.
ISSN:1543-8384
1543-8392
DOI:10.1021/acs.molpharmaceut.5b00954